Significance of the FGFR3 mutation in Chinese patients with bladder cancer.

Authors:
Hao L; Fang J; Xu R; Liu S; Luo G and 1 more

Journal:
Transl Androl Urol

Publication Year: 2023

DOI:
10.21037/tau-23-247

PMCID:
PMC10251100

PMID:
37305616

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Transl Androl Urol

Abbreviation: Transl Androl Urol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Urology & Nephrology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Efficacy of medication for overactive bladder symptoms in 70 patients with Parkinson's disease.
Jia C; Cui X; Ou T. (2024) - Transparency Score: 3/6
Inflatable penile prosthesis placement in Peyronie's disease: a review of surgical considerations, …
Good J; Crist N; Henderson B and 3 more (2024) - Transparency Score: 3/6
Machine learning algorithms being an auxiliary tool to predict the overall survival of patients wit…
Jiang W; Chen Z; Chen C and 3 more (2024) - Transparency Score: 3/6
Management of the distal ureter and bladder cuff at the time of nephroureterectomy: an overview of …
Pathak RA; Hemal AK. (2024) - Transparency Score: 3/6
Narrative review of nephron-sparing surgical management of upper tract urothelial carcinoma: is the…
Saini S; Deveshwar SP; Hemal AK. (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tau.amegroups.com/article/view/10.21037/tau-23-247/coif). All authors report the technical support from Shanghai Tongshu Biotechnology Co., Ltd. The authors have no other conflicts of interest to declare."

Evidence found in paper:

"Funding: This work was supported by the Project of Science and Technology Bureau of Xiamen (Nos. 3502Z20184033 and 3502Z20194022), the Natural Science Foundation of Fujian Province (No. 2020J011213), and the Young/Middle-aged Talent Cultivation Project that was funded by the Fujian Provincial Health and Family Planning Commission and Xiamen Health and Family Planning Commission (No. 2021GGB028)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025